First Patient Enrolled in Abiomed's RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock
First trial in AMI cardiogenic shock to use the FDA’s EFIC protocol
Source: dicardiology.com
Inova Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Inova Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Inova Study Today - Breaking & Trending Today
Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock
Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).
Source: news-medical.net